![PE133010: β-GalNAc-PEG3-Amine Pack Size:100 mg 2-[2-(2-Prop-2-ynoxyethoxy)ethoxy]ethyl 2-acetamido-2-deoxy-α-D-galactopyranoside](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/PE133010-R_3df46fa2-3a6d-45cd-8b7f-29176c933edc.svg?v=1700576981)
Pay in 4 interest-free payments of $50.00 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
2-[2-(2-Prop-2-ynoxyethoxy)ethoxy]ethyl 2-acetamido-2-deoxy-α-D-galactopyranoside
64 / / Canagliflozin-3-O-β-D-Glucuronide / Canagliflozin-3-Glucuronide
38 / An α-D-N-acetylgalactosamine (GalNAcα) ligand equipped with an azide handle through a hydrophilic PEG3 spacer
a tumor-associated carbohydrate antigen and Siglec ligand
β-D-Gal-Et-SH
PE133010: β-GalNAc-PEG3-Amine Pack Size:100 mg 2-[2-(2-Prop-2-ynoxyethoxy)ethoxy]ethyl 2-acetamido-2-deoxy-α-D-galactopyranosideC14H28N2O9 352. 38 A D N acetylgalactosamine (GalNAc) ligand equipped with a primary amine through a hydrophilic PEG3 spacer. The amine couples with NHS activated esters to form stable amide bonds, providing a route to conjugate the ligand onto NHS activated molecules and surfaces. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the asialoglycoprotein receptor (ASGPR), which is highly
